1 week ago

Stocks in News: IPO Debuts, Stake Sales, and Corporate Updates

Stocks in News: IPO Debuts, Stake Sales, and Corporate Updates
Top stocks in news: RIL, Horizon Parks, Meesho, Lalithaa, Bank of Baroda, Lenskart, Power Grid · businesstoday.in

Several companies have important stock-market updates.

Two companies, Lalithaa Jewellery Mart and Horizon Industrial Parks, are expected to list their shares on August 24.

Investors bought many more shares of Lalithaa Jewellery Mart than were available, while Horizon Industrial Parks received fewer bids.

Some early investors may sell parts of their holdings in Meesho and Lenskart Solutions.

Reliance Industries received shareholder approval for new business activities and related-party transactions.

Power Grid won work to build a transmission system for renewable-energy projects in Gujarat.

NTPC Renewable Energy won a contract to supply renewable power at a stated tariff.

Bank of Baroda raised $400 million by issuing bonds.

Four pharmaceutical companies reported inspections by the United States Food and Drug Administration, with observations at each of the inspected facilities.

Key facts

Lalithaa Jewellery Mart IPO
Raised Rs 1,700 crore at Rs 201 per share; the issue was subscribed more than 66.6 times.
Horizon Industrial Parks IPO
Raised Rs 2,600 crore at Rs 60 per share; the issue was subscribed a little more than 1.5 times.
Reported block deals
Y Combinator may sell up to 1.05% of Meesho, while SoftBank Vision Fund II Lightbulb Cayman may sell up to 2.6% of Lenskart Solutions.
Reliance Industries
Shareholders approved material related-party transaction proposals and an expanded objects clause covering explosives, fertilisers and agro-chemicals.
Power Grid Corporation of India
Was declared the successful bidder for an inter-state renewable-energy transmission system in Gujarat at a discovered tariff of Rs 822.91 crore per annum.
Bank of Baroda notes
Completed a $400 million issue of senior unsecured fixed-rate notes with a five-year original maturity and a 5.389% all-in yield.
Pharmaceutical inspections
Aurobindo Pharma reported one USFDA observation, Natco Pharma four, Caplin Point Laboratories 10 and Choksi Laboratories four.

Sources

Related news